Adherence with statin therapy in elderly patients with and without acute coronary syndromes

JAMA

Volumn 288, Issue 4, 2002, Pages 462-467

  Jackevicius, Cynthia A ^a,b,c   Mamdani, Muhammad ^b,c   Tu, Jack V ^b,c,d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL;

EID: 0037167013     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.4.462     Document Type: Article

References (32)

1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
6. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
7. Withdrawal of statins increases event rates in patients with acute coronary syndromes
8. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings?
9. Apparent discontinuation rates in patients prescribed lipid-lowering drugs
10. Persistence of use of lipid-lowering medications: A cross-national study
11. Adherence with and efficacy of treatment with pravastatin and cholestyramine: A randomized study on lipid-lowering in primary care
12. Impact of medication nonadherence on coronary heart disease outcomes: A critical review
13. Understanding and improving patient compliance
14. Use of the statins in patients after acute myocardial infarction: Does evidence change practice?
15. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction
16. The assessment of refill compliance using pharmacy records: Methods, validity, and applications
17. The problem of adherence to cholesterol altering therapy
18. Discontinuation rates of cholesterol-lowering medications: Implications for primary care
19. Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction
20. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study
21. Early statin treatment following acute myocardial infarction and 1-year survival
22. Recommendations for the management and treatment of dyslipidemia
23. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
24. Compliance and adverse event withdrawal: Their impact on the West of Scotland Coronary Prevention Study
25. Compliance with antihypertensive therapya shifting paradigm
26. Comparative dose efficacy of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia
27. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality
28. The influence of hospital-based prescribers on prescribing in general practice
29. Recall of recommendations and adherence to advice among patients with chronic medical conditions
30. Helping patients follow the treatments you prescribe